WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For some people, dozens of U.S.-approved drugs can lead to a rare but often fatal brain infection. Researchers have now confirmed a strong link between four genetic mutations and this illness, called progressive multifocal leukoencephalopathy (PML). A new study found that in peopleContinue Reading

FRIDAY, Dec. 9, 2022 (HealthDay News) — Black patients with brain tumors may be less likely to have surgery recommended to them than white patients are, according to a large U.S. study. The research, which looked at two national databases, found that on average, Black patients were less likely toContinue Reading

FRIDAY, Dec. 9, 2022 (HealthDay News) — Former elite football players may age faster than their more average peers, a new study suggests. NFL players, especially former linemen, had fewer disease-free years and earlier high blood pressure and diabetes diagnoses. Two age-related diseases, arthritis and dementia, were also more commonlyContinue Reading

TUESDAY, Dec. 6, 2022 (HealthDay News) — Chips, pizza, cookies: Delicious, but a diet full of ultra-processed foods like these may contribute to brain deterioration, researchers report. Ultra-processed foods have lots of added and unhealthy ingredients, such as sugar, salt, fat, artificial colors and preservatives. Examples include frozen meals, softContinue Reading

MONDAY, Dec. 5, 2022 (HealthDay News) — Growing numbers of Americans are suffering prolonged, life-threatening seizures known as status epilepticus, and Black people are nearly twice as likely to experience these seizures as white people. These are the main findings from new research looking at hospitalizations for status epilepticus fromContinue Reading

FRIDAY, Dec. 2, 2022 (HealthDay News) — Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research. Spending on antiseizure medications more than doubled in eight years for the government insurers, largely because of third-generation and brand-nameContinue Reading

TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety. A 65-year-old woman with early-stage Alzheimer’s recently died from a massive brain bleed that some researchers link to lecanemab, anContinue Reading